Format

Send to

Choose Destination
Int J Tuberc Lung Dis. 2010 Feb;14(2):203-9.

Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.

Author information

1
Municipal Health Secretariat, Rio de Janeiro, Rio de Janeiro, Brazil. drsocavalcante@yahoo.com.br

Abstract

SETTING:

Central Rio de Janeiro, Brazil.

OBJECTIVE:

To compare the impact of routine DOTS vs. enhanced DOTS (DOTS-Ampliado or DOTS-A) on tuberculosis (TB) incidence.

DESIGN:

Cluster-randomized trial in eight urban neighborhoods pair-matched by TB incidence and randomly assigned to receive either the DOTS-A or DOTS strategy. DOTS-A added intensive screening of household contacts of active TB cases and provision of treatment to secondary cases and preventive therapy to contacts with latent TB infection (LTBI) to the standard DOTS strategy. The primary endpoint was the TB incidence rates in communities after 5 years of intervention.

RESULTS:

From November 2000 to December 2004, respectively 339 and 311 pulmonary TB cases were enrolled and 1003 and 960 household were identified in DOTS and DOTS-A communities. Among contacts from DOTS-A communities, 26 (4%) had active TB diagnosed and treated, 429 (61.3%) had LTBI detected and 258 (60.1%) started preventive therapy. TB incidence increased by 5% in DOTS communities and decreased by 10% in DOTS-A communities, for a difference of 15% after 5 years (P = 0.04).

CONCLUSION:

DOTS-A was associated with a modest reduction in TB incidence and may be an important strategy for reducing the burden of TB.

PMID:
20074412
PMCID:
PMC3812056
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Ingenta plc Icon for PubMed Central
Loading ...
Support Center